Maryland State Retirement & Pension System’s Nektar Therapeutics NKTR Stock Holding History

Maryland State Retirement & Pension System’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,165	Closed	-$175K	–	1535
2022 Q4	$175K	Buy	+5,165	New	+$250K	0.01%	1470
2022 Q3	–	Sell	-4,977	Closed	-$284K	–	933
2022 Q2	$284K	Sell	4,977 -880	-15%	-$55.5K	0.01%	1297
2022 Q1	$473K	Buy	5,857 +72	+1%	+$10.7K	0.01%	1097
2021 Q4	$1.17M	Buy	5,785 +4,905	+557%	+$1.06M	0.03%	558
2021 Q3	$238K	Hold	880	–	–	0.01%	1452
2021 Q2	$223K	Hold	880	–	–	0.01%	918
2021 Q1	$264K	Buy	+880	New	+$274K	0.01%	915

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Maryland State Retirement & Pension System's NKTR Position: Q1 2023 in Review

Maryland State Retirement & Pension System sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 5,165 shares — an estimated $175K sold.

Maryland State Retirement & Pension System first reported a position in NKTR in Q1 2021 and held it in 7 quarters. The position peaked at $1.17M in Q4 2021. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

Maryland State Retirement & Pension System reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
Maryland State Retirement & Pension System sold 5,165 Nektar Therapeutics shares in Q1 2023, an estimated $175K.
Maryland State Retirement & Pension System first reported a position in Nektar Therapeutics in Q1 2021 and held it in 7 quarters.
Maryland State Retirement & Pension System's Nektar Therapeutics position peaked at $1.17M in Q4 2021.
194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on Maryland State Retirement & Pension System's 13F filing for Q1 2023, filed 20 Apr 2023.